Ending the Opioid Epidemic Webinar Series: Webinar 4.

Webinar Title: Medication Assisted Treatment in a Rural Clinic: Challenges and Opportunities

Medication Assisted Treatment (MAT), is the use of FDA-approved medications, in combination with counseling and behavioral therapies, to provide a "whole-patient" approach to the treatment of substance use disorders.  The regulated amount of medication provided in MAT addresses opioid withdrawal symptoms. In this webinar, the presenter will examine the MAT process in a rural setting as well as the challenges and opportunities faced by clinicians who provide MAT to their clients.

By the end of the webinar, participants will be able to

1. Identify four benefits of Medication-Assisted Treatment (MAT)

2. Differentiate between schedule I, II and III drugs

3. Discuss the challenges of MAT implementation in a rural area

4. Describe three facilitators of successful implementation of MAT in a rural clinic

Speaker

Durand Warren, MEd, MBA, NCC, LPC, ALPS
Director of Behavioral Health
Williamson Health and Wellness Center, West Virginia

Bradley R. Barnett, MEd, NCC, LPC, LCADC, AADC
Regional Coordinator
OVP Health, West Virginia

Audience

This webinar series is appropriate for physicians, nurses, social workers, case managers, public health practitioners, and other health professionals who would benefit from the information.

Disclosure(s)

Planners have no conflicts of interest relative to this educational activity. Speakers have no conflicts of interest to disclose.

Ending the Opioid Epidemic Webinar Series

Series Description:

The MidAtlantic AIDS Education and Training Center and the Mid-Atlantic Regional Public Health Training Center have created a six-part interactive webinar series which has been designed to introduce diverse strategies for success in ending the opioid epidemic. Participants will hear from legal, social, medical, and community intervention experts in a strategy-gathering information exchange. The webinars will be an hour in length and will include Q&A as well as audience interaction via polling. We welcome you to join us for the entire series or for individual webinars such as this one!